Managing Director & Senior Partner
Andrew Rodriguez is a core member of the Health Care, Strategy, and Corporate Development practices at Boston Consulting Group.
Since joining BCG in 2002, Andrew has acquired broad health care experience in multiple sectors, focusing on biopharmaceuticals, vaccines, and global health. His clients have included multinational companies, foundations, and international organizations. As a core member of the firm’s global-health team, he has worked extensively on a range of assignments with the Bill & Melinda Gates Foundation.
Before joining BCG, Andrew was a strategic-planning manager with the worldwide beverage-company Diageo and cofounder of the business accelerator Techwell.
Stakeholder support is crucial for ensuring that African vaccine-manufacturing companies can produce sufficient supply for the continent.
Antimicrobial resistance is difficult to combat. This report gives a comprehensive assessment of vaccine R&D potential against pathogens with high levels of AMR.
Once a visionary ambition, synthetic control arms are poised to take off. Now is the time for pharma companies to identify opportunities and gain experience.
Pharmaceutical companies can take four steps today to adapt their approach to clinical development and drive value by the end of 2020.